Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Effective anti-PD-1 therapy reduces neutrophil infiltration via T cell-macrophage chemokine axis in hepatocellular carcinoma.

OBJECTIVE Immune checkpoint inhibitor (ICI) therapies, such as anti-PD-1 treatment, have achieved great success in various cancers, including hepatocellular carcinoma. Tumor-infiltrating lymphocytes have major roles in the mechanism of action for ICIs, but numerous other components of the tumor microenvironment also co...

Jia-Hao Huang, Bo-Yang Yi, Kuo Qi et al. · 0 citations
Open access Sep 2026

RBM25 Drives Hepatocellular Carcinoma Progression by Stabilizing YAP Through Regulating Oncogenic Splicing‐switch of MYPT1

This work identifies RNA‐binding motif protein 25 (RBM25) as a potent oncogenic driver that is overexpressed in HCC and correlates with dismal patient prognosis and nominate RBM25 as a viable prognostic biomarker and therapeutic target.

Wen-Jing Zhang, Li-Li Zhi, Tian Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.